1. Allotransplantation Section, Hematology Branch, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD;
2. Cell Processing Section, Department of Transfusion Medicine, NIH, Bethesda, MD;
3. Kiadis Pharma (formerly Celmed), Saint-Laurent, QC; and
4. Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom